Nutriband CEO Publishes Letter to Shareholders

Stock Information for Janel Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Janel Corp

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
FDA Grants Nutriband Meeting Request for Aversa(TM) Fentanyl Abuse Deterrent Fentanyl Patch
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.